Anthem Blue Cross Connecticut Commercial Clinical Policy

Anthem Blue Cross Connecticut LAB.00049 Artificial Intelligence-Based Software for Prostate Cancer Detection Form

Effective Date

01/03/2024

Last Reviewed

11/09/2023

Original Document

  Reference



This document addresses the use of artificial intelligence-based software that analyzes prostate biopsy slides to assist accurate cytopathologic diagnosis.

Note: Please see the following related document for additional information:

  • LAB.00026 Systems Pathology and Multimodal Artificial Intelligence Testing for Prostate Cancer

Position Statement

Investigational and Not Medically Necessary:

Use of artificial intelligence-based software for prostate cancer detection is considered investigational and not medically necessary for all indications.

Want to learn more?